Superior High-End Bioanalytical Solutions

Superior High-End Bioanalytical Solutions

Syneos HealthTM provides high-quality bioanalytical services across the entire continuum of drug development.

We have more than 25 years of experience in developing and validating immunoassays with small and large molecules, peptides, immunochemistry, LC-MS/MS, HRMS, GC-MS/MS, and ICP-MS.

With its two GLP-compliant North American bioanalytical labs in Quebec City, Canada, and in Princeton, New Jersey, Syneos Health acts as a pioneer and key player in the bioanalysis world. The expertise of our scientists combined with the high-level of technology that we invest in, allow us to adapt to the rapidly changing bioanalytical requirements that result in major challenges to our clients.

Innovative Technology in Mass Spectrometry

Through our advanced technology, our processes provide improved precision, better reproducibility and fewer errors. We are expanding our services in the biotherapeutics area, with the addition of high-resolution instruments. To always serve our clients better, Syneos Health has recently acquired:

? 2 Sciex 6500+ LC-MS/MS systems ? 2 Thermo iCAPTM RQ

ICP-MS systems ? 2 Waters Xevo G2-XS QToF

high resolution mass specs

These state-of-the-art technologies allow us to be the best partner to take on the accelerated evolving bioanalytical challenges faced by our clients in the course of their drug development.

Our Laboratories Offer Complete Analytical Support for:

? Preclinical studies ? Bioavailability and drug

metabolism studies ? Bioequivalence studies ? Clinical study

compliance samples ? Drug interaction studies

? 2018 Syneos HealthTM. All rights reserved.

Contact Us

contact-us

At a glance: ? 300 dedicated professionals ? 72 triple quadrupole mass specs including (API 6500+, 5000TM and 4000TM) ? 850,000 samples analyzed per year ? More than 1,000 validated assays available, extensive method development capabilities (>120 new assays every year) and rapid data-handling capabilities ? LC-MS/MS: 65 systems ? Waters? Xevo TQ-S (5) ? Sciex 6500+ (3), 5000 (25), 4000 (32) ? Waters ACQUITY? UPLC? M-Class System (21, 2 with IonKey) ? Shimadzu UPLCs (4) ? Cohesive Systems for dual injection (6) ? GC-MS/MS: 7 systems ? Agilent? GC-MS/MS (2) ? Finnigan TSQ 700/7000 (5) ? LC-HRMS: 3 systems ? Xevo? G2-XS QTof (2) ? Thermo ScientificTM ExactiveTM Plus Orbitrap (1) ? 25 Robotic systems ? Hamilton? STARTM and STARletTM (6) ? Tomtec? Quadra 96, Quadra 4? (13) ? Janus? (4)

Visit our website to access over 1,000 validated methods or contact us for more information.

Contact Us Today

contact-us

About Syneos Health

Syneos HealthTM (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies ? INC Research and inVentiv Health ? we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers' delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to lifeTM visit .

? 2018 Syneos HealthTM. All rights reserved.

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download